On the other hand, for tumor-infiltrating immune cells, PD-L1 was positive in 100.0% (13/13) of LELCC and 20.0% (3/15) of IHCC cases (P < 0.001) (Table 4). The gene discussed is CD274; the disease is neoplasm.